543848

- Dev Labtech Venture Limited has announced an Extra Ordinary General Meeting (EGM) scheduled for Thursday, 5th November, 2026 at 1:00 p.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). - The meeting will consider increasing the Authorised Share Capital from ₹25,00,00,000 to ₹31,00,00,000 and amending the Memorandum of Association. - It includes a proposal to issue up to 1,37,00,000 Convertible Warrants on a preferential basis at ₹13 each, aggregating ₹17,81,00,000 to promoter and non-promoter allottees.

- Dev Labtech Venture Ltd announced an increase in its authorized share capital from ₹25 crores to ₹31 crores. - Board approved the issuance of up to 1,37,00,000 convertible warrants at ₹13 each on a preferential basis, aggregating to ₹17.81 crores. - An Extra Ordinary General Meeting (EGM) is scheduled for November 5, 2026, with a cut-off date of October 29, 2026.

- The Board of Directors approved increasing the Authorized Share Capital from ₹25 Crore to ₹31 Crore. - Approved issuing up to 1,37,00,000 convertible warrants at ₹13 each on a preferential basis, aggregating to ₹17.81 Crore. - Convened an Extra Ordinary General Meeting (EGM) on November 5, 2026, with a cut-off date of October 29, 2026.

- Board approved increasing authorized share capital from ₹25 crores to ₹31 crores by altering the Memorandum of Association. - Approved issuing up to 1,37,00,000 convertible warrants at ₹13 each (face value ₹5, premium ₹8) on a preferential basis, aggregating to ₹17.81 crores to promoters and non-promoters. - Fixed EGM date for 5th November, 2026, with a cut-off date of 29th October, 2026, for voting.

- Dev Labtech Venture Ltd announced a board meeting outcome on October 7, 2026. - Approved increasing Authorized Share Capital from ₹25 Crore to ₹31 Crore. - Approved issuing up to 1,37,00,000 convertible warrants at ₹13 each on a preferential basis, aggregating to ₹17.81 Crore. - Scheduled an Extra Ordinary General Meeting (EGM) on November 5, 2026.